JPMorgan, AQR, and Rhumbline Advisers lifted holdings in Phathom Pharmaceuticals on June 17, 2026.
3 reports, 3 independent
Updated Jul 30
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
JPMorgan, AQR, and Rhumbline Advisers lifted holdings in Phathom Pharmaceuticals on June 17, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Executives provided guidance on solid growth and discount ranges.1 source
Holding lifts reported for Phathom Pharmaceuticals (PHAT) on 06/17/2026.1 source
Keep exploring
Part of
Analyst reports are affecting stock price targets for various companies, with company data being summarized on financial blogs.Also in this story
- Jefferies Financial Group restated its buy rating on Paylocity, while Truist Financial cut its target price.
- Financial firms including Bank of America, Morgan Stanley, and Truist Financial adjusted price targets and ratings for Somnigroup International Inc.
- Truist Financial issued a buy rating for a company, with MarketBeat providing average rating data.
- Analyst firms provided research reports and aggregated market data for Sensata Technologies.